Please wait a minute...
Reviews in Cardiovascular Medicine  2018, Vol. 19 Issue (4): 123-127     DOI: 10.31083/j.rcm.2018.04.3187
Review Previous articles | Next articles
The Cardiovascular effects of chocolate
Jose P. Garcia1, Adrian Santana2, Diego Lugo Baruqui3, Nicholas Suraci4, *()
1 Florida Atlantic University Medical School, Boca Raton, Florida. 33431
2 Johns Hopkins University, Baltimore, Maryland. 21218
3 Department of Internal Medicine. Mount Sinai Medical Center, Miami Beach, Florida. 33140
4 Department of Anesthesiology. Mount Sinai Medical Center, Miami Beach, Florida. 33140
Download:  PDF(408KB)  ( 256 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
The antioxidants as polyphenols, especially flavanols present in cocoa, exert a favorable effect on endothelium vasodilation, modulate inflammatory markers, and decrease platelet aggregation, lipid oxidation and insulin resistance. Recent nutritional intervention trials and molecular studies demonstrate that consumption of cocoa, particularly rich in flavanols, is beneficial to promote cardiovascular health. This review describes the cardiovascular effects of chocolate.
Key words:  Chocolate      flavanols      cardiovascular      nitric oxide     
Published:  30 December 2018     
*Corresponding Author(s):  Nicholas Suraci, E-mail: nicholas.suraci@gmail.com   

Cite this article: 

Jose P. Garcia, Adrian Santana, Diego Lugo Baruqui, Nicholas Suraci. The Cardiovascular effects of chocolate. Reviews in Cardiovascular Medicine, 2018, 19(4): 123-127.

URL: 

https://rcm.imrpress.org/EN/10.31083/j.rcm.2018.04.3187     OR     https://rcm.imrpress.org/EN/Y2018/V19/I4/123

[1] Baba S, Osakabe N, Kato Y, et al. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. The American Journal of Clinical Nutrition. 2007;85:709-717.
[2] Conen D, Chiuve SE, Everett BM, et al. Caffeine consumption and incident atrial fibrillation in women. The American Journal of Clinical Nutrition. 2010;92:509-514.
[3] Dong JY, Iso H, Yamagishi K, et al. Japan Public Health Center- based Prospective Study Group. Chocolate consumption and risk of stroke among men and women: A large population-based, prospective cohort study. Atherosclerosis. 2017;260:8-12.
[4] Gong F, Yao S, Wan J, et al. Chocolate consumption and risk of heart failure: a meta-analysis of prospective studies. Nutrients. 2017;9:402.
[5] Gu L, House SE, Wu X, et al. Procyanidin and catechin contents and antioxidant capacity of cocoa and chocolate products. Journal of Agricultural and Food Chemistry. 2006;54:4057-4061.
[6] Hammer A, Koppensteiner R, Steiner S, et al. Dark chocolate and vascular function in patients with peripheral artery disease: A randomized, controlled cross-over trial. Clin Hemorheol Microcirc. 2015;59:145-153.
[7] Khawaja O, Gaziano JM, Djoussé L. Chocolate and coronary heart sisease: systematic review. Current Atherosclerosis Reports. 2011;13:447-452.
[8] Khawaja O, Petrone AB, Kanjwal Y, et al. Chocolate Consumption and Risk of Atrial Fibrillation (From the Physicians’ Health Study). American Journal of Cardiology. 2015;116:563-566.
[9] Kwok CS, Boekholdt SM, Lentjes MA, et al. Habitual chocolate consumption and risk of cardiovascular disease among healthy men and women. Heart. 2015;101:1279-1287.
[10] Larsson SC, Åkesson A, Gigante B, et al. Chocolate consumption and risk of myocardial infarction: a prospective study and metaanalysis. Heart. 2016;102:1017-1022.
[11] Larsson SC, Drca N, Jensen-Urstad M, et al. Chocolate consumption and risk of atrial fibrillation. Two cohort studies and a metaanalysis. American Heart Journal. 2018;195:86-90.
[12] Loffredo L, Perri L, Catasca E, et al. Dark chocolate acutely improves walking autonomy in patients with peripheral artery disease. Journal of the American Heart Association. 2014;3:1-9.
[13] Mostofsky E, Berg Johansen M, Tjønneland A, et al. Chocolate intake and risk of clinically apparent atrial fibrillation: the Danish Diet, Cancer, and Health Study. Heart. 2017; 103:1163-1167.
[14] Mostofsky E, Levitan EB, Wolk A, et al. Chocolate intake and the incidence of heart failure. A population-based prospective study of middle-aged and elderly women. Circulation: Heart Failure. 2010;3:612-616.
[15] Noad RL, Rooney C, McCall D, et al. Beneficial effect of a polyphenol-rich diet on cardiovascular risk: a randomised control trial. Heart. 2016;102:1371-1379.
[16] Persson IA, Persson K, Hagg S, et al. Effects of cocoa extract and dark chocolate on angiotensin-converting enzyme and nitric oxide in human endothelial cells and healthy volunteers-a nutrigenomics perspective. Journal of Cardiovascular Pharmacology. 2011;57:44-50.
[17] Ried K, Fakler P, Stocks NP. Effect of cocoa on blood pressure. Cochrane Database of Systematic Reviews. 2017;25:1-120.
[18] Rostami A, Khalili M, Haghighat N, et al. High-cocoa polyphenolrich chocolate improves blood pressure in patients with diabetes and hypertension. ARYA Atherosclerosis. 2015;11:21-29.
[19] Tokede OA, Gaziano JM, Djoussé L. Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis. European Journal of Clinical Nutrition. 2011;65:879-886.
[20] Sarriá B, Martínez-López S, Sierra-Cinos JL, et al. Regular consumption of a cocoa product improves the cardiometabolic profile in healthy and moderately hypercholesterolaemic adults. British Journal of Nutrition. 2014;111:122-134.
[21] Steihaus D, Mostofsky E, Levitan E, Mittleman M. Chocolate intake and incidence of Heart Failure: Findings form the Cohort of Swedish Men. American Heart Journal.2017;183:18-23.
[22] Yuan S, Li X, Jin Y, et al. Chocolate consumption and risk of coronary heart disease, stroke, and diabetes: a meta-analysis of prospective studies. Nutrients. 2017;9:1-10.
[1] Rudaynah A. Alali. A short review of proprotein convertase subtilisin/kexin type 9 inhibitors[J]. Reviews in Cardiovascular Medicine, 2019, 20(1): 1-8.
[2] Jennifer G. Robinson, Karol E. Watson. Identifying Patients for Nonstatin Therapy[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 1-8.
[3] Janani Rangaswami, Sandeep Soman, Peter A. McCullough. Key updates in Cardio-Nephrology from 2018: springboard to a bright Future[J]. Reviews in Cardiovascular Medicine, 2018, 19(4): 113-116.
[4] Davide Bolignano, Anna Pisano, Graziella D’Arrigo. Pulmonary hypertension: a neglected risk condition in renal patients?[J]. Reviews in Cardiovascular Medicine, 2018, 19(4): 117-121.
[5] Peter A. McCullough, Aaron Y. Kluger, Kristen M. Tecson, Clay M. Barbin, Andy Y. Lee, Edgar V. Lerma, Zachary P. Rosol, Sivan L. Kluger, Janani Rangaswami. Inhibition of the Sodium–Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2[J]. Reviews in Cardiovascular Medicine, 2018, 19(2): 51-63.
[6] Akanksha Agrawal, Deepanshu Jain, Eyob L. Feyssa, Aman M. Amanullah. Utility of Dobutamine Stress Echocardiography in Cardiac Risk Stratification of Patients Undergoing Orthotopic Liver Transplantation[J]. Reviews in Cardiovascular Medicine, 2017, 18(4): 146-154.
[7] Alberto Palazzuoli, Helen Hashemi, Lauren C. Jameson, Peter A. McCullough. Hyperuricemia and Cardiovascular Disease[J]. Reviews in Cardiovascular Medicine, 2017, 18(4): 134-145.
[8] Claudio Ronco, Federico Ronco, Peter A. McCullough. A Call to Action to Develop Integrated Curricula in Cardiorenal Medicine[J]. Reviews in Cardiovascular Medicine, 2017, 18(3): 93-99.
[9] Ankit B. Shah, Neil Coplan. Cardiovascular Effects of Altitude on Performance Athletes[J]. Reviews in Cardiovascular Medicine, 2016, 17(1-2): 49-56.
[10] Boback Ziaeian, John Dinkler, Karol Watson. Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial[J]. Reviews in Cardiovascular Medicine, 2015, 16(2): 125-130.
[11] Tariq Bhat, Adi Neuman, Mohmad Tantary, Hilal Bhat, Daniel Glass, William Mannino, Muhammad Akhtar, Alina Bhat, Sumaya Teli, James Lafferty. Inhaled Nitric Oxide in Acute Pulmonary Embolism: A Systematic Review[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 1-8.
[12] Vasiliki Katsi, Manolis S. Kallistratos, Antonios N. Pavlidis, Nikos Karpettas, Ioannis Skoumas, Nikonas Pavleros, Athanasios J. Manolis, Christos Pitsavos, Dimitris Tousoulis, Christodoulos Stefanadis, Ioannis Kallikazaros. The Mystery of High-density Lipoprotein: Quantity or Quality? Update on Therapeutic Strategies[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 9-19.
[13] Li-Mei Liao, Mary G. Carey. Laboratory-induced Mental Stress, Cardiovascular Response, and Psychological Characteristics[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 28-35.
[14] Norman E. Lepor, Dean D. Fouchia, Peter A. McCulloughsup. New Vistas for the Treatment of Obesity: Turning the Tide Against the Leading Cause of Morbidity and Cardiovascular Mortality in the Developed World[J]. Reviews in Cardiovascular Medicine, 2014, 15(S2): 1-21.
[15] Virginia A. Triant. Epidemiology of Coronary Heart Disease in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 1-8.
[1] Evgeniy A. Cheremushkin,Nadezda E. Petrenko,Irina A. Yakovenko,Sergei A. Gordeev,Nikolay N. Alipov,Olga V. Sergeeva. Human neurophysiological markers of high anxiety level during preparation for visual recognition[J]. Journal of Integrative Neuroscience, 2018, 17(3): 193 -202 .
[2] Miao Xie, Geng Zhang, Wei Yin, Xin-Xin Hei, Tao Liu. Cognitive enhancing and antioxidant effects of tetrahydroxystilbene glucoside in Aβ1-42-induced neurodegeneration in mice[J]. Journal of Integrative Neuroscience, 2018, 17(3): 203 -210 .
[3] Elena L. Teslenko,Elena V. Damyanovich,Ilija Damjanović,Zoran Gačić,Boris K. Baziyan. Saccadic dysfunction in patients with hypoxic-ischemic encephalopathy[J]. Journal of Integrative Neuroscience, 2018, 17(3): 211 -220 .
[4] Andrey F. Iznak,Ekaterina V. Iznak,Tatiana P. Klyushnik,Georgy M. Kobel'kov,Elena V. Damjanovich,Igor V. Oleichik,Lilia I. Abramova. Neurobiological parameters in quantitative prediction of treatment outcome in schizophrenic patients[J]. Journal of Integrative Neuroscience, 2018, 17(3): 221 -228 .
[5] Renata S. Marcomini,Ana Claúdia F. Frizzo,Viviane B. de Góes,Simone F. Regaçone,David M. Garner,Rodrigo D. Raimundo,Fernando R. Oliveira,Vitor E. Valenti. Association between heart rhythm and cortical sound processing[J]. Journal of Integrative Neuroscience, 2018, 17(3): 229 -236 .
[6] Elham Askari,Seyed Kamaledin Setarehdan,Ali Sheikhani,Mohammad Reza Mohammadi,Mohammad Teshnehlab. Computational model for detection of abnormal brain connections in children with autism[J]. Journal of Integrative Neuroscience, 2018, 17(3): 237 -248 .
[7] Faraj Al-Marri, Faruque Reza, Tahamina Begum, Wan Hazabbah Wan Hitam, Goh Khean Jin, Jing Xiang. Neural activation patterns and connectivity in visual attention during number and non-number processing: An ERP study using Ishihara pseudoisochromatic plates[J]. Journal of Integrative Neuroscience, 2018, 17(3): 257 -270 .
[8] Xian Liu,Chunyu Zhao,Chengxia Sun,Zhanming Chen,Tasawar Hayat,Ahmed Alsaedi. A new closed-loop strategy for detection and modulation of epileptiform spikes based on cross approximate entropy[J]. Journal of Integrative Neuroscience, 2018, 17(3): 271 -280 .
[9] Gerardo Fernández,Nora P. Rotstein,Luis E. Politi,Liliana Castro,Osvaldo Agamennoni. Microsaccadic behavior when developing a complex dynamical activity[J]. Journal of Integrative Neuroscience, 2018, 17(3): 287 -290 .
[10] Alexander Fedotchev,Grigoriy Radchenko,Anna Zemlianaia. Music of the brain approach to health protection[J]. Journal of Integrative Neuroscience, 2018, 17(3): 291 -296 .